ECO Animal Health Group plc ("ECO" or the "Company")

Director/PDMR Shareholding and Notification

The Company was notified today by the following Directors of the Company of the exercise and subsequent sale of 245,000 options, all at a price of £4.75, at various costs per ordinary share of 5 pence each in the Company ("Ordinary Share"), being Ordinary Shares granted as unapproved share options under the Executive Share Option Scheme.

Director

Position

Holding pre option exercise and share sale

Options exercised and then sold (“Sale”)

Option cost per Ordinary Share

Options held post Sale

Ordinary Share holding post Sale %

Marc Loomes

CEO

1,430,000

150,000

196p

1,280,000

NIL

Kevin Stockdale

Finance Director

467,500

45,000

226p

422,500

NIL

Julia Trouse

Executive Director

422,500

50,000

196p

372,500

NIL

Following these transactions, the Company’s issued ordinary share capital consists of 64,987,706 Ordinary Shares. Each Ordinary Share carries one vote. Accordingly, the number of Ordinary Shares with voting rights in issue is 64,987,706.

1.		Details of the person discharging managerial responsibilities / person closely associated
a.		Name		1. Marc Loomes 2. Kevin Stockdale 3. Julia Trouse
2.		Reason for the notification
a.		Position/status		1. CEO 2. Finance Director 3. Executive Director
b.		Initial notification /Amendment		Initial notification
3.		Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.		Name		ECO Animal Health Group plc
b.		LEI		01818170
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.		Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 5p each GB0032036807
b.		Nature of the transaction		1. Exercise of 150,000 options under the Executive Share Option Scheme 2. Exercise of 45,000 options under the Executive Share Option Scheme 3. Exercise of 50,000 options under the Executive Share Option Scheme
c.		Price(s) and volume(s)		Price(s) 1. 196p 2. 226p 3. 196p		Volume(s) 150,000 45,000 50,000
d.		Aggregated information · Aggregated volume · Price		Price(s) 1. 196p 2. 226p 3. 196p		Volume(s) 150,000 45,000 50,000
e.		Date of the transaction		2016-10-13
f.		Place of the transaction		London Stock Exchange (XLON) AIM market
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.		Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 5p each GB0032036807
b.		Nature of the transaction		1. Sale of 150,000 shares arising from the exercise of options under the Executive Share Option Scheme 2. Sale of 45,000 shares arising from the exercise of options under the Executive Share Option Scheme 3. Sale of 50,000 shares arising from the exercise of options under the Executive Share Option Scheme
c.		Price(s) and volume(s)		Price(s) 1. 475p 2. 475p 3. 475p		Volume(s) 150,000 45,000 50,000
d.		Aggregated information  · Aggregated volume  · Price		Average price(s) 1. 475p 2. 475p 3. 475p		Total volume(s) 150,000 45,000 50,000
e.		Date of the transaction		2016-10-13
f.		Place of the transaction		London Stock Exchange (XLON) AIM market

Enquiries

ECO Animal Health Group plc

Peter Lawrence, Executive Chairman 020 8336 6190

Marc Loomes, CEO 020 8447 8899

Spiro Financial

Anthony Spiro 020 8336 6196

Peel Hunt LLP (Nominated Adviser)

Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900

View source version on businesswire.com: http://www.businesswire.com/news/home/20161013006124/en/